News & Events
Crinetics Announces June 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals announces June 2023 inducement grants: the stock options were granted as inducements material to 14 employees entering into...
READ MORECrinetics to Highlight Broad Pipeline at ENDO 2023
Crinetics Pharmaceuticals highlighting broad pipeline at ENDO 2023 with oral and poster presentations on several programs, including candidates for primary hyperparathyroidism...
READ MORECrinetics Announces May 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals announces May 2023 inducement grants: the stock options were granted as inducements material to nine employees entering into...
READ MORECrinetics Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
Crinetics Pharmaceuticals reported financial results and provided an update on first quarter 2023 clinical progress
READ MORECrinetics Announces April 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals announces April 2023 inducement grants: the stock options were granted as inducements material to 15 employees entering into...
READ MORECrinetics Announces March 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals announces March 2023 inducement grants: the stock options were granted as inducements material to eight employees entering into...
READ MORECrinetics Reports Fourth Quarter and Full Year 2022 Financial Results
Crinetics Pharmaceuticals reported financial results for the fourth quarter and year ended December 31, 2022
READ MORECrinetics Announces February 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals announces February 2023 inducement grants: the stock options were granted as inducements material to six employees entering into...
READ MORECrinetics Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference
Crinetics Pharmaceuticals will participate in a fireside chat at the annual SVB Securities Global Biopharma Conference on February 14, 2023.
READ MORETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.